Oxycodone in Combination With Parathoracic Nerve Block is Used for Postoperative Analgesia in Lung Cancer

• Status: Not yet recruiting
• Trial end date: 2024-12-31
• Target enrollment: 0
• Participant gender: All

Summary

In this study, the effect of oxycodone combined with ultrasound-guided paravertebral nerve block on the postoperative analgesic effect of thoracoscopic lung cancer was investigated, and the effect and reasonable dose of oxycodone were explored, which provided a reference for the clinical multimodal analgesia after thoracoscopic lung cancer surgery.

• Phase: Phase 1
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Qianfoshan Hospital
• Treatments: Oxycodone; Sufentanil

Criteria

Inclusion Criteria:

1. Male or female, age > 60 years

2. Patients undergoing thoracoscopic lobectomy

3. ASA (American Academy of Anesthesiologists) Grades I-III

4. There were no obvious abnormalities in heart, liver, and kidney function

5. Sign the informed consent form for this clinical study

Exclusion Criteria:

1. History of oxycodone or sufentanil allergy

2. Renal or hepatic dysfunction

3. History of drug or alcohol abuse

4. Psychiatric disorders: schizophrenia, epilepsy, Parkinson's disease, myasthenia gravis

5. Those who have difficulty communicating due to coma, severe dementia, speech barrier, or those who cannot cooperate due to other diseases.

6. People with head trauma or other brain diseases -